Many imaging and serologic tests have been evolved to help predict the occurrence of congenital disease. One such test is the maternal serum alpha-fetoprotein screening test (MS-AFP). The MS-AFP test ...

An AFP blood test (also known as a 'maternal serum alpha-fetoprotein' or 'MSAFP') is used to assess the likelihood that a pregnant woman's baby will have a 'neural tube defect' (or NTD). Neural tube ...

ABBOTT PARK, Ill., March 28, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular ...

Abbott announced that the FDA has approved Architect AFP, a test to help detect serious birth defects and the progression of testicular cancer. Alpha-fetoprotein (AFP) is a biomarker that can identify ...

A race-based adjustment to test-result values from a common prenatal screening should be discontinued, according to a study published this week in Obstetrics and Gynecology. The adjustment has ...

Pregnant women in most countries worldwide are currently offered prenatal screening for spina bifida and other birth defects. The test results are not 100% accurate and there are some false positive ...